2017 Industry Person of the Year: Dana Maiman, CEO and President, FCB Health
Dana Maiman brings the intellectual prowess and strategic rigor of a legal education to her position as the CEO and president of the FCB Health family of companies worldwide.
Also a member of FCB’s Global Executive Team, Maiman has combined her strategic orientation with a single-minded commitment to client service, resulting in the healthcare network’s impressive growth under her leadership. In recent years, she has broadened her focus from one office, FCB Health, to a network of companies including Area 23, FCBCURE, FCBHalesway, FCBVIO, Hudson Global, ICC London, Mosaic, Neon, ProHealth, and TBD (The Branding & Design Group).
Her 20 years of client service and healthcare marketing experience mean Maiman has worked in virtually every therapeutic category, from antibacterials, women’s healthcare, and cardiovascular to diabetes, oncology, and HIV in a multichannel fashion, integrating professional, consumer, patient, payer, and digital. She has been involved with numerous U.S. and global launches, including Yervoy, Opdivo, Gilenya, Stelara, Entresto, Cialis, Januvia, Fosamax Once-Weekly, and Nuvigil, among others. Her clients include pharmaceutical companies big and small, such as AbbVie, Allergan, Amgen, Bayer, Boehringer Ingelheim, Genentech, Janssen, Merck, Novartis, and Pfizer.
Among Maiman’s many accolades are being named the No. 24 Health Influencer by Medical Marketing & Media and her agencies being named Agency of the Year by various publications six times, including being named North American Agency of the Year by the Global Awards in 2016.
A graduate of Brandeis University and St. John’s University School of Law, as well as a member of the New York State Bar, Maiman has worked within the FCB network since 1999. Prior to joining the agency, she served as director of client services for both Grey and Harrison & Star/Omnicom in New York.